BIOMEDICAL DEVELOPMENT CORPORATION

Basic Information

A152 ASTeCC Building
Lexington, KY, 40506-

Company Profile

n/a

Additional Details

Field Value
DUNS: 145377966
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Long-Term Broad-Spectrum Prevention of Implant-Related Infections

    Amount: $162,266.00

    DESCRIPTION (provided by applicant): Deep wound infection following total joint arthroplasty is a devastating complication for physician and patient, a leading cause of morbidity, and a significant ec ...

    STTR Phase I 2012 Department of Health and Human Services
  2. Vestibular-Topographical Memory Markers for Those At Risk for Alzheimer's Disease

    Amount: $199,759.00

    DESCRIPTION (provided by applicant): Despite years of research, the cause of Alzheimer's disease remains essentially unknown. Topographic memory impairments are arguably the earliest cognitive de ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. Nonlinear Computation Tool to Chart Trajectories of Bipolar Disorder

    Amount: $498,269.00

    DESCRIPTION (provided by applicant): Bipolar disorder is an inherently complex chronic illness characterized by recurrent, dramatic mood changes. Management of bipolar disorder typically consists of a ...

    STTR Phase I 2011 Department of Health and Human Services
  4. Unique Anti-microbial Rinse to Reduce Oral Inflammation

    Amount: $710,270.00

    DESCRIPTION (provided by applicant): Periodontal disease has been recently identified as a risk factor for increased morbidity and mortality for systemic diseases such as pancreatic cancer, cardiovas ...

    SBIR Phase II 2010 Department of Health and Human Services
  5. Unique Anti-microbial Rinse to Reduce Oral Inflammation

    Amount: $344,781.00

    DESCRIPTION (provided by applicant): Periodontal disease has been recently identified as a risk factor for increased morbidity and mortality for systemic diseases such as pancreatic cancer, cardiovas ...

    SBIR Phase I 2009 Department of Health and Human Services
  6. Novel Therapy to Treat Otitis Media

    Amount: $107,000.00

    DESCRIPTION (provided by applicant): Otitis media is a common childhood disease with annual direct costs estimated to exceed 3 billion. Otitis media is the most frequent cause of pediatric practition ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. Treatment and/or Prevention of Urinary Tract Infections

    Amount: $226,733.00

    DESCRIPTION (provided by applicant): Urinary tract infections (UTIs) are very common bacterial infections that affect millions of people each year. In the U.S., approximately 10% of women are diagnose ...

    STTR Phase I 2008 Department of Health and Human Services
  8. Novel Rinse to Treat Oral Candidiasis in Cancer Patients

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): Oral candidiasis (oropharyngeal candidosis or thrush) is a common infection in immunosuppressed individuals, and, if not blunted, can transit to esophageal candido ...

    SBIR Phase II 2006 Department of Health and Human Services
  9. Novel Topical Treatment of Eczema

    Amount: $134,645.00

    DESCRIPTION (provided by applicant): Irritant and allergic contact dermatitis affect approximately 10% of adults, and hand eczema represents one of the four most common occupationally related diseases ...

    SBIR Phase I 2006 Department of Health and Human Services
  10. Non-Toxic Gel to Treat Vulvovaginal Candidiasis

    Amount: $110,322.00

    DESCRIPTION (provided by applicant): The goal of this project is to develop a safe biocidal vaginal gel for treatment of vulvovaginal candidiasis (WC). WC is caused by one of several airborne species ...

    SBIR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government